Neudopa Tablet

Description

1. Neudopa Tablet contains Levodopa + Carbidopa as a tablet, marketed by Platinum Pharmaceuticals (Pvt) Ltd.. Category: Anti-Parkinson / Neurological.
2. Levodopa is the aromatic amino acid converted in body to dopamine, a neurotransmittor deficient in Parkinson’s disease. Carbidopa is inhibitor of L-aromatic amino acid decarboxylase, also called dopa decarboxylase.
3. Used for: Dopa-responsive dystonia, Parkinsonism, Parkinson’s disease, Parkinson’s disease (but not drug-induced extrapyramidal symptoms), Restless legs syndrome; Dopa-responsive dystonia, Parkinsonism, Parkinson’s disease, Postencephalitic parkinsonism, Symptomatic parkinsonism.
4. Precautions: It should be used with caution in patients with glaucoma, history of skin cancer, breathing problems, heart, kidney, liver, endocrine disease, ulcers, depression or blood disorders. Carbidopa should be used with caution in patients with glaucoma, history of skin cancer, breathing problems, heart, kidney, liver, endocrine disease, ulcers, depression or blood disorders.
5. Storage: Tab, Caps Store Below 40°C. Protect from Sunlight and Moisture.. Pack: see packaging. Use only as directed; check expiry and DRAP registration on the pack.